The U.S. Preventive Services Task Force (USPSTF) recommends screening pregnant women for hepatitis B virus (HBV) infection at their first prenatal visit (A recommendation).
The US Food and Drug Administration is allowing onto the market the first new hepatitis B vaccine in more than 25 years with the approval of Dynavax’ Heplisav-B.